Kalderos is a pharma-tech company that combines industry expertise, design thinking and technology to target waste and to improve efficiency as the category leader in healthcare network management.

Kalderos delivers technology that solves the challenges facing the US healthcare system.

Kalderos was founded in 2016 by Jeremy Docken and David de Vogel. The company is headquartered in Chicago, Illinois.

Kalderos is on a mission to solve systemic problems of the healthcare system, redefining how the business of healthcare performs.

Kalderos' initial SaaS product is the world's first drug discount management solution, which identifies, checks, and resolves non-compliance. Using sophisticated models and machine learning processes, Kalderos detects inconsistencies overlooked by current methods, providing material benefits by eliminating waste.


Kalderos works with 10 drug manufacturers and over 2,500 providers in all 50 U.S. states. Recently, Kalderos launched its provider-facing Review platform to support 340B-covered entities in their claims review process. There’s also Kalderos Pay, a tool designed to enable manufacturers to work with providers to facilitate the exchange of drug discounts on a single platform.


Kalderos is backed by Bain Capital Ventures and Mercato Partners. The company raised $28M in Series B round on June 15, 2020. This brings Kalderos' total funding to $35M to date.



  • Year founded: 2016
  • Funding Info: $35M over 2 Rounds (Latest Funding Type: Series B)
  • Yearly Revenue: NA
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: Chicago
  • State: Illinois
  • Country: United States
Related businesses